FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009223871> ?p ?o ?g. }

• W2009223871 endingPage "501" @default.
• W2009223871 startingPage "493" @default.
• W2009223871 abstract "Objectives. The aim of this study was to assess whether prostaglandia endoperoxides, which continue to be formed in the setting of thromboxane A2synthase inhibition, might influence the fate of ischemic myocardium in a model of coronary occlusion and reperfusion. Background. It was recently demonstrated that thromboxane A2synthase inhibitors reduce ischemic myocardial injury through a redirection of prostaglandin (PG) endoperoxides toward the synthesis of “cardioprotective” prostaglandins, such as PGI2, PGE2and PGD2. However, part of these prostaglandin endoperoxides may also stimulate a receptor, shared with thromboxane A2, mediating piutelet aggregation and vasoconstriction. Methods. New Zealand White rabbits were subjected to 30 min of coronary occlusion, followed by 5.5 h of reperfusion. Fifteen minutes before reperfusion, the animals were randomized to receive 1) saline solution (control animals, n = 8); 2) SQ 29548, a potent and selective thromboxane A2/PGH2receptor antagonist (n = 8); 3) dazoxiben, a selective thromboxane A2synthase inhibitor (n = 8); 4) R 68070 (Ridogrel), a drug with dual thromboxane A2synthase-inhibiting and thromboxane A2/PGH2receptor-blocking properties (n = 8); or 5) aspirin + R 68070 (n = 8). Results. Dazoxiben and R 68070, but not SQ 29548, significantly reduced thromboxane B2formation and increased plasma levels of 6-keto-PGF10, PGE2and PGF2a. Ex vivo platelet aggregation induced by U46619 (a thromboxane A2mimetic) was inhibited by SQ 29548 and R 68070 but not by dazoxiben. In control animals, infarct size determined at the end of the experiment by triphenyltetrazolium chloride staining averaged 57.7 ± 3.2% of the area at risk of infarction. The administration of SQ 29548 did not significantly reduce infract size compared with that in control animals, whereas dazosxiben and R 68070 significantly reduced infarct size to 36.7 ± 2.8% and 16.6 ± 3.6% of area at risk of infarction, respectively (p < 0.001 vs. control values). In rabbits treated with R 68070, infract size was also significantly smaller than that of dazoxiben-treated rabbits (p < 0.01). This protective effect of R 68070 was completely abolished when the drug was administered with aspirin, infarct size in this group averaging 59.7 ± 1.6% (p = NS vs. control values). No differences in regional myocardial blood flow, systemic blood pressure, heart rate or extent of area at risk were observed among groups. Conclusions. Thus, prostaglandin endoperoxides play an important role in modulating the cardioprotective effects of thromboxane A2synthase inhibitors. The simultaneous inhibition of thromboxane A2synthase and blockade of thromboxane A2/PGH2receptors by R 68070 identify a pharmacologic interaction of potential therapeutic importance." @default.
• W2009223871 created "2016-06-24" @default.
• W2009223871 creator A5036209306 @default.
• W2009223871 creator A5041185771 @default.
• W2009223871 creator A5044760713 @default.
• W2009223871 creator A5051324603 @default.
• W2009223871 creator A5061421060 @default.
• W2009223871 creator A5065523983 @default.
• W2009223871 creator A5070748471 @default.
• W2009223871 creator A5084170977 @default.
• W2009223871 creator A5089212884 @default.
• W2009223871 date "1993-02-01" @default.
• W2009223871 modified "2023-10-16" @default.
• W2009223871 title "Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: Studies in a rabbit model of coronary artery occlusion-reperfusion" @default.
• W2009223871 cites W1913184930 @default.
• W2009223871 cites W1963860018 @default.
• W2009223871 cites W1966049708 @default.
• W2009223871 cites W1981801926 @default.
• W2009223871 cites W1985682506 @default.
• W2009223871 cites W1990082411 @default.
• W2009223871 cites W1991117742 @default.
• W2009223871 cites W2003882152 @default.
• W2009223871 cites W2007453848 @default.
• W2009223871 cites W2009908559 @default.
• W2009223871 cites W2010694924 @default.
• W2009223871 cites W2010786943 @default.
• W2009223871 cites W2011691751 @default.
• W2009223871 cites W2032456247 @default.
• W2009223871 cites W2033327514 @default.
• W2009223871 cites W2038443634 @default.
• W2009223871 cites W2047349143 @default.
• W2009223871 cites W2047785103 @default.
• W2009223871 cites W2047830083 @default.
• W2009223871 cites W2051153718 @default.
• W2009223871 cites W2058329709 @default.
• W2009223871 cites W2058994566 @default.
• W2009223871 cites W2064287942 @default.
• W2009223871 cites W2072772602 @default.
• W2009223871 cites W2075279086 @default.
• W2009223871 cites W2080478165 @default.
• W2009223871 cites W2083244656 @default.
• W2009223871 cites W2086928528 @default.
• W2009223871 cites W2087895681 @default.
• W2009223871 cites W2088180729 @default.
• W2009223871 cites W2089406251 @default.
• W2009223871 cites W2109733205 @default.
• W2009223871 cites W2115332175 @default.
• W2009223871 cites W2117730908 @default.
• W2009223871 cites W2129042092 @default.
• W2009223871 cites W2131414371 @default.
• W2009223871 cites W2140233303 @default.
• W2009223871 cites W2210345112 @default.
• W2009223871 cites W2248295501 @default.
• W2009223871 cites W2272087247 @default.
• W2009223871 cites W2400176514 @default.
• W2009223871 cites W2415291423 @default.
• W2009223871 cites W2417667988 @default.
• W2009223871 cites W2472542224 @default.
• W2009223871 doi "https://doi.org/10.1016/0735-1097(93)90694-v" @default.
• W2009223871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8426016" @default.
• W2009223871 hasPublicationYear "1993" @default.
• W2009223871 type Work @default.
• W2009223871 sameAs 2009223871 @default.
• W2009223871 citedByCount "21" @default.
• W2009223871 countsByYear W20092238712020 @default.
• W2009223871 crossrefType "journal-article" @default.
• W2009223871 hasAuthorship W2009223871A5036209306 @default.
• W2009223871 hasAuthorship W2009223871A5041185771 @default.
• W2009223871 hasAuthorship W2009223871A5044760713 @default.
• W2009223871 hasAuthorship W2009223871A5051324603 @default.
• W2009223871 hasAuthorship W2009223871A5061421060 @default.
• W2009223871 hasAuthorship W2009223871A5065523983 @default.
• W2009223871 hasAuthorship W2009223871A5070748471 @default.
• W2009223871 hasAuthorship W2009223871A5084170977 @default.
• W2009223871 hasAuthorship W2009223871A5089212884 @default.
• W2009223871 hasConcept C126322002 @default.
• W2009223871 hasConcept C173202427 @default.
• W2009223871 hasConcept C181199279 @default.
• W2009223871 hasConcept C185592680 @default.
• W2009223871 hasConcept C2776785769 @default.
• W2009223871 hasConcept C2777628954 @default.
• W2009223871 hasConcept C2779689624 @default.
• W2009223871 hasConcept C2780664492 @default.
• W2009223871 hasConcept C2781024287 @default.
• W2009223871 hasConcept C2781080829 @default.
• W2009223871 hasConcept C42219234 @default.
• W2009223871 hasConcept C51603380 @default.
• W2009223871 hasConcept C55493867 @default.
• W2009223871 hasConcept C71924100 @default.
• W2009223871 hasConcept C89560881 @default.
• W2009223871 hasConcept C98274493 @default.
• W2009223871 hasConceptScore W2009223871C126322002 @default.
• W2009223871 hasConceptScore W2009223871C173202427 @default.
• W2009223871 hasConceptScore W2009223871C181199279 @default.
• W2009223871 hasConceptScore W2009223871C185592680 @default.
• W2009223871 hasConceptScore W2009223871C2776785769 @default.
• W2009223871 hasConceptScore W2009223871C2777628954 @default.
• W2009223871 hasConceptScore W2009223871C2779689624 @default.

• next